Rallybio Corporation (RLYB)
NASDAQ: RLYB · Real-Time Price · USD
0.6618
-0.0048 (-0.72%)
At close: Dec 5, 2025, 4:00 PM EST
0.6626
+0.0008 (0.12%)
After-hours: Dec 5, 2025, 5:34 PM EST
Rallybio Market Cap
Rallybio has a market cap or net worth of $27.96 million as of December 5, 2025. Its market cap has decreased by -29.84% in one year.
Market Cap
27.96M
Enterprise Value
-31.16M
1-Year Change
-29.84%
Ranking
Category
Stock Price
$0.66
Market Cap Chart
Since the IPO on July 29, 2021, Rallybio's market cap has decreased from $405.60M to $27.96M, a decrease of -93.11%. That is a compound annual growth rate of -45.88%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 5, 2025 | 27.96M | -29.81% |
| Dec 31, 2024 | 39.83M | -55.91% |
| Dec 29, 2023 | 90.33M | -63.67% |
| Dec 30, 2022 | 248.60M | -18.90% |
| Dec 31, 2021 | 306.52M | -24.43% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 904.62B |
| Johnson & Johnson | 486.51B |
| AbbVie | 399.57B |
| UnitedHealth Group | 299.75B |
| AstraZeneca | 280.82B |
| Novartis AG | 255.15B |
| Merck & Co. | 247.51B |
| Abbott Laboratories | 217.50B |